“May See Turnaround In Growth Across EMs”
  • Prabha Hedge
  • Nov 01 2013

November 1: Glenn Saldanha, MD & CEO, Glenmark Pharmaceuticals, says, “The overall business environment continues to be challenging across the EMs.”